17th ACTO Annual meeting
The 17th Annual Meeting of the Asian Cellular Therapy Organization (ACTO), held in collaboration with the Indonesian Stem Cell Association (ASPI).
Programme Highlights :
- Advancing research and clinical translation of cell-based therapies
- Multidisciplinary sessions involving academicians, clinicians, industry, and government
- Scientific, regulatory, clinical, and public sessions
- Organization and networking meetings
More information: ACTO HQ
ISCT 2026
THE LARGEST GLOBAL CELL & GENE THERAPY TRANSLATION CONFERENCE.
Cutting-edge CGT translational education driving real-world impact. Access the data and discover the developments that are shaping the future of healthcare. Join scientific innovators, clinicians, lab professionals, industry experts, and global regulators for sector-shaping discussions and debates.
More information:
https://www.isctglobal.org/annual-meeting/home
CGT ASIA 2026
This conference will deeply focus on the latest developments in cell and gene drug research, analyzing the trends and integration applications of core technologies such as immune cell therapy, gene therapy for rare diseases, gene editing, in vivo CAR-T technology, mesenchymal stem cells, and AAV vectors, and accelerating the transition of innovative therapies from the laboratory to practical use. In addition, the summit will bring together top scientists, clinical researchers, business leaders and policy experts from Asia, jointly outlining the development path and commercial future of cell and gene therapy in the next stage.
More information:
https://genetherapy-asia.taaslabs.com
ISEV 2026
The ISEV Annual Meeting is the premier scientific conference in the field of extracellular vesicles. We bring together the top researchers and scientists from around the world, showcasing cutting edge research in session rooms and cutting edge technology on the exhibits floor. The ISEV Annual Meeting has grown to over 1,200 attendees annually.
More information:
https://www.isev.org/isev-annual-meeting
APSEV 2026
This year’s meeting will be held in conjunction with APSEV 2026, organized by the Asia Pacific Society for Extracellular Vesicles.
Building upon Japan’s pioneering achievements in extracellular vesicle (EV) research from basic science to applied studies, we aim to send a strong message to the world about the future of EV research from Japan, as leading researchers across the Asia-Pacific region gather together. Accordingly, the joint conference theme is “Beyond Exosome.”
More information:
https://www.ace-enterprise.jp/apsev-jsev2026/en_index.html
ISSCR- iPSC 20th Anniversary Symposium
The discovery of induced pluripotent stem cell (iPSC) technology has revolutionized biomedical research and regenerative medicine.
To celebrate the 20th anniversary of this transformative breakthrough, the ISSCR is bringing together the global stem cell community in Kyoto, the birthplace of iPS cells, for a three-day symposium. This program will reflect on two decades of remarkable progress and explore the future of the field.
More information:
https://www.isscr.org/upcoming-programs/2026-kyoto-international-symposium
VOL. 2, ISSUE 4 (AUTUMN EDITION)
This issue features highlights from the 16th ACTO Annual Congress in Singapore, academic insights into cartilage cell sheet engineering, and updates on cellular and gene therapy (CGT) advances and industrial developments. Through expert perspectives, regulatory discussions, and translational research updates, this edition reflects ACTO’s continued commitment to advancing regenerative medicine and fostering global collaboration.
VOL. 2, ISSUE 3 (SUMMER EDITION)
This edition addresses details of the 16th annual meeting in Singapore, the regulatory landscape for cell and gene therapy in Singapore, how circadian rhythm shapes life, regulatory mechanisms in skin stem cells and cancer, a stem cell-based therapeutic perspective for primary ovarian insufficiency, and APSEV spotlight.
VOL. 2, ISSUE 2 (SPRING EDITION)
This edition addresses details of the 16th annual meeting in Singapore, the regulatory landscape for cell and gene therapy in Singapore, trends of Mesenchymal Stem Cell (MSCs) therapy, FDA’s shift away from animal testing, and recent clinical applications of extracellular vesicles (EVs).
14-16 AUGUST 2025
Academia, SGH Campus, 20 College Road, Singapore 169856
The Asian Cellular Therapy Organization is be holding its 16th annual congress (ACTO 2025) in Singapore, in partnership with the SingHealth Duke-NUS Cell Therapy Centre from the 14th to 16th August 2025.
This important event will focus on cell and gene therapy with an Asian perspective, addressing key regulatory issues, topics such as MSCs and Exosomes, and country-specific reports that highlight the latest developments in this vital
field across participating nations. The Asian region is marked by its genetic and cultural richness, alongside significant population dynamics, creating a unique environment for nuanced discussions.
Our organization prides itself on inclusivity, fostering collaboration among diverse stakeholders to drive robust and sustainable advancements in cell and gene therapy.
This in-person meeting will provide a valuable platform for collaboration across research, clinical, manufacturing, and regulatory realms. Attendees will have the opportunity to engage with leading experts and share insights that can shape the future of our industry.
Detailed information: https://www.acto2025.com
THE ACTO TIMES 